Hedge fund billionaire John Paulson has been named as the new chairman at Bausch, according to a report by Bloomberg.
Paulson replaces Jospeh Papa who resigned earlier this week. His decision to leave is reported to have no connection to “any dispute or disagreement”
Paulson, the company’s second-largest shareholder, has taken on the position with immediate effect.
Bausch Health is a pharmaceutical and device company with a focus on eye care, gastroenterology and dermatology products.
